Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avraham Karasik

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
Annals of Medicine|July 16, 2005
Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuumAvraham Karasik
Diabetes Technology & Therapeutics|May 3, 2003
Glucose correlation with light scattering patterns--a novel method for non-invasive glucose measurementsOhad Cohen, Ilya Fine, Emanuel Monashkin, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 4, 2005
Successful pregnancy after unilateral adrenalectomy in a case of primary pigmented adrenocortical diseaseOhad Cohen, Shany Bogat, Mordechai Dolitzki, et al.
European Journal of Endocrinology|March 12, 2004
Compliance with follow-up and the informative value of diagnostic whole-body scan in patients with differentiated thyroid carcinoma given recombinant human TSHOhad Cohen, Sari Dabhi, Avraham Karasik, et al.
The Lancet. Oncology|February 3, 2005
Diabetes mellitus and breast cancerIdo Wolf, Siegal Sadetzki, Raphael Catane, et al.
Diabetes Care|November 30, 2006
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin aloneBernard Charbonnel, Avraham Karasik, Ji Liu, et al.
Endocrinology|February 28, 2002
Aurintricarboxylic acid induces a distinct activation of the IGF-I receptor signaling within MDA-231 cellsMichal Haimsohn, Rachel Beery, Avraham Karasik, et al.
Journal of Biomedical Informatics|September 13, 2022
Temporal patterns selection for All-Cause Mortality prediction in T2D with ANNsPavel Novitski, Cheli Melzer Cohen, Avraham Karasik, et al.
Diabetes Research and Clinical Practice|March 9, 2025
Drug adherence, glycemic control, and weight reduction with subcutaneous semaglutide in real-world management of type 2 diabetesCheli Melzer Cohen, Ofri Mosenzon, Alona Aharonovich, et al.
Diabetes & Vascular Disease Research|January 22, 2009
Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trialMarkolf Hanefeld, Avraham Karasik, Carsta Koehler, et al.
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
Annals of Medicine|July 16, 2005
Glycaemic control is essential for effective cardiovascular risk reduction across the type 2 diabetes continuumAvraham Karasik
Diabetes Technology & Therapeutics|May 3, 2003
Glucose correlation with light scattering patterns--a novel method for non-invasive glucose measurementsOhad Cohen, Ilya Fine, Emanuel Monashkin, et al.
The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|August 4, 2005
Successful pregnancy after unilateral adrenalectomy in a case of primary pigmented adrenocortical diseaseOhad Cohen, Shany Bogat, Mordechai Dolitzki, et al.
European Journal of Endocrinology|March 12, 2004
Compliance with follow-up and the informative value of diagnostic whole-body scan in patients with differentiated thyroid carcinoma given recombinant human TSHOhad Cohen, Sari Dabhi, Avraham Karasik, et al.
The Lancet. Oncology|February 3, 2005
Diabetes mellitus and breast cancerIdo Wolf, Siegal Sadetzki, Raphael Catane, et al.
Diabetes Care|November 30, 2006
Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin aloneBernard Charbonnel, Avraham Karasik, Ji Liu, et al.
Endocrinology|February 28, 2002
Aurintricarboxylic acid induces a distinct activation of the IGF-I receptor signaling within MDA-231 cellsMichal Haimsohn, Rachel Beery, Avraham Karasik, et al.
Journal of Biomedical Informatics|September 13, 2022
Temporal patterns selection for All-Cause Mortality prediction in T2D with ANNsPavel Novitski, Cheli Melzer Cohen, Avraham Karasik, et al.
Diabetes Research and Clinical Practice|March 9, 2025
Drug adherence, glycemic control, and weight reduction with subcutaneous semaglutide in real-world management of type 2 diabetesCheli Melzer Cohen, Ofri Mosenzon, Alona Aharonovich, et al.
Diabetes & Vascular Disease Research|January 22, 2009
Metabolic syndrome and its single traits as risk factors for diabetes in people with impaired glucose tolerance: the STOP-NIDDM trialMarkolf Hanefeld, Avraham Karasik, Carsta Koehler, et al.
Pageof 7